The Risk of Acute and Delayed Hemolytic Reactions in Pediatric Patients Receiving Allogeneic Peripheral Blood Stem Cell Products

Key Points

• Acute and delayed hemolytic reactions occur in pediatric patients after receiving allogeneic peripheral blood stem cells.
• The incidence of these reactions highlights the importance of monitoring transfusion protocols and patient outcomes.
• This assessment involved a detailed review of pediatric patient records and transfusion histories across multiple centers.
• These findings prompt a call for stricter safety measures and protocols to reduce hemolytic risk in pediatric transfusions.